ArticleInternational journal of immunopathology and pharmacology

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma.

Maximilian Johannes Steinhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.